0
The US has experienced a policy debate as to whether competition from biosimilars is the best strategy for achieving price reductions for biologicals or, rather, whether direct price regulation aft...
More >- Home
-
Generics
News
- Sandoz launches ferumoxytol and pemetrexed generics
- US generic approvals for Acrux and Cipla
- Natco cancer generic approval and advances for Lannett asthma and diabetes products
- FDA approval for schizophrenia and HIV generics from Zydus Cadila and Lupin
-
Biosimilars
News
- Bioeq submits application for ranibizumab biosimilar to FDA
- CuraTeQ submits application to EMA for pegfilgrastim biosimilar
- EMA recommends approval of two adalimumab biosimilars
- EC and FDA approval for first ranibizumab biosimilar Byooviz
- MORE EDITORIAL SECTIONS
- Search
